How understanding immunology contributes to managing CMV disease in immunosuppressed patients: now and in future (Q38432092)

3 September 2017

1 reference

title

How understanding immunology contributes to managing CMV disease in immunosuppressed patients: now and in future (English)

1 reference

3 September 2017

1 reference

2

1 reference

3 September 2017

J G Patrick Sissons

1

1 reference

3 September 2017

21 April 2015

1 reference

Medical Microbiology and Immunology

3 September 2017

1 reference

3 September 2017

204

1 reference

3 September 2017

3

1 reference

3 September 2017

307-316

1 reference

https://scigraph.springernature.com/pub.10.1007/s00430-015-0415-0

3 September 2017

0 references

cites work

Natural killer cell deficiency

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Severe herpesvirus infections in an adolescent without natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Human NK cell response to pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Expansion of CMV-mediated NKG2C+ NK cells associates with the development of specific de novo malignancies in liver-transplanted patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8(+) T cell response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Dynamics of T cell memory in human cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Molecular regulation of effector and memory T cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Deep sequencing of antiviral T-cell responses to HCMV and EBV in humans reveals a stable repertoire that is maintained for many years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Behavior and function of tissue-resident memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Human cytomegalovirus immunity and immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Human cytomegalovirus manipulation of latently infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Cytomegalovirus microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Latency-associated degradation of the MRP1 drug transporter during latent human cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4⁺ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+ T-cell migration and suppression of effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Clinical Trials of Immunization with the Towne 125 Strain of Human Cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Immune recovery uveitis: pathogenesis, clinical symptoms, and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Development of cytomegalovirus (CMV) immune recovery uveitis is associated with Th17 cell depletion and poor systemic CMV-specific T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Intraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Cytomegalovirus-specific T cell immunotherapy promotes restoration of durable functional antiviral immunity following allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

CMV-specific T cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Chimeric antigen receptor T cells for sustained remissions in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Human Cytomegalovirus Latency: Targeting Differences in the Latently Infected Cell with a View to Clearing Latent Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0415-0

Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients

21 January 2018

1 reference

12 December 2020

Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance

1 reference

12 December 2020

An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling

1 reference

12 December 2020

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

12 December 2020

Latency and reactivation of human cytomegalovirus

1 reference

12 December 2020

The intimate relationship between human cytomegalovirus and the dendritic cell lineage

1 reference

12 December 2020

10.1007/S00430-015-0415-0

Identifiers

DOI

1 reference

PubMed ID

25896527

Dimensions Publication ID

3 September 2017

0 references

1 reference

PubMed ID

25896527